AZNCF News and Press, AstraZeneca Plc From 07/21/23

2023-07-21 11:08:50 ET Summary On July 27, 2023, Bristol-Myers Squibb, one of the leaders in the global cancer and immunology therapeutics market, will release its financial report for the second quarter of 2023. In the first half of 2023, the company delighted investors with nume...

2023-07-16 02:49:02 ET Summary Renalytix's lead product, KidneyIntelX, an AI diagnostic tool for kidney disease, has received FDA approval and established insurance reimbursement, partnerships, and a sales team. The KidneyIntelX platform combines a blood test and data from patient...

2023-06-20 07:27:45 ET Summary AstraZeneca is considering spinning off its China operations and listing a separate division in Hong Kong or Shanghai. This move could protect the company's Chinese sales. In 2022, China accounted for 13% of AstraZeneca's total sales, making it an at...

2023-06-06 07:17:10 ET AstraZeneca PLC (AZN) ASCO Investor Event June 5, 2023 19:00 ET CorporateParticipants Andy Barnett - VP Global Head of IR Roy Herbst - Deputy Director, Yale Cancer Center Pascal Soriot - Chief Executive Officer Susan Galbraith - Executi...

2023-05-25 11:02:29 ET Summary AstraZeneca's price has moved sideways in the past month, after showing good progress for some time. A look at its numbers reveals that it is going strong, and will continue to do so in the foreseeable future. However, it is fairly valued at this tim...

2023-05-16 16:46:23 ET Summary We continue our analytics coverage of AstraZeneca PLC with a "hold" rating for the next 12 months. AstraZeneca's revenue for the first three months of 2023 was $10.88 billion, down 2.9% from the previous quarter and 4.5% from the first quarter of 202...

2023-05-14 03:56:00 ET Summary Industry-leading pharmaceutical firms are adopting artificial intelligence to drive value for the future of their enterprise. Several companies in the VanEck Pharmaceutical ETF are currently integrating AI into their operations. The global pharma...

2023-05-04 04:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron International Growth Fund gained 3.75% (Institutional Shares) during the first q...

2023-05-01 06:39:12 ET The following slide deck was published by AstraZeneca PLC in conjunction with this event. For further details see: AstraZeneca (AZN) Presents at the 2023 American Association for Cancer Research (AACR) - Slideshow

2023-04-27 14:12:14 ET AstraZeneca PLC (AZN) Q1 2023 Earnings Conference Call April 26, 2023, 06:45 AM ET Company Participants Andy Barnett - VP Global Head of IR Pascal Soriot - CEO Aradhana Sarin - CFO Dave Fredrickson - EVP of Oncology Business Unit Su...